文献速递间质性肺疾病肺栓塞与肺血管病

间质性肺疾病相关肺动脉高压:系统综述与荟萃分析

Pulmonary Hypertension in Interstitial Lung Disease: A Systematic Review and Meta-Analysis.
PubMed 文献 · Chest · 2024-05-29

右心导管检查(RHC)定义的PH汇总患病率为36%(95%CI 30%-42%),经胸超声心动图(TTE)为34%(95%CI 29%-38%)。PH与症状负担增加及预后不良相关。

要点

  • ILD患者中PH汇总患病率:RHC定义36%(95%CI 30%-42%),TTE定义34%(95%CI 29%-38%)。
  • DLCO降低、氧合差、运动能力下降、肺动脉/主动脉比值及肺动脉直径增加、BNP升高与PH相关。
  • PH存在与症状负担增加和预后更差相关,干预试验结局聚焦肺血管血流动力学和6分钟步行距离。

核心结论

  • PH是ILD常见并发症,具有显著健康影响。
  • 有必要标准化PH定义,并基于已识别的相关因素前瞻性评估风险分层。
  • 研究结果为未来ILD相关PH干预试验中替代终点的验证提供证据基础。

研究设计与样本

  • 系统综述与荟萃分析,检索Ovid MEDLINE、Embase和CENTRAL数据库。
  • 纳入评估任何病因ILD患者中PH的原始研究,PH定义基于研究者标准。

主要发现

  • 常用诊断检查为右心导管检查(56%)和经胸超声心动图(50%)。
  • RHC定义的PH汇总患病率为36%(95%CI 30%-42%),TTE定义为34%(95%CI 29%-38%)。
  • 至少60%的研究报告DLCO降低、氧合状态更差、运动能力下降、肺动脉/主动脉比值及肺动脉直径增加、血清BNP升高与PH存在相关。
  • PH存在与症状负担增加和预后更差相关。
  • 干预试验结局指标聚焦肺血管血流动力学变化和6分钟步行距离。

关键数值与推荐

  • PH定义基于研究者标准,未统一。
  • 汇总患病率:RHC 36%(95%CI 30%-42%),TTE 34%(95%CI 29%-38%)。
  • 相关因素在至少60%的研究中一致报告。

临床怎么用

  • 临床应关注ILD患者中PH的常见性,对存在DLCO降低、氧合差、运动能力下降、肺动脉增宽或BNP升高者评估PH。
  • 诊断PH时需注意RHC和TTE定义的患病率差异,RHC为常用确诊工具。
  • PH存在提示症状负担更重和预后更差,需加强管理。

局限性

  • PH定义基于研究者标准,各研究诊断评估方法不一。
  • 纳入研究为原始研究,异质性可能影响汇总结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary hypertension (PH) is a key complication in interstitial lung disease (ILD), with recent therapeutic advances. RESEARCH QUESTION: What are the diagnostic evaluation, epidemiologic features, associated factors, prognostic significance, and outcome measures in interventional trials for PH in patients with ILD in the current literature? STUDY DESIGN AND METHODS: The Ovid MEDLINE, Embase, and CENTRAL databases were searched for original research evaluating PH in participants with ILD of any cause. The definition of PH was based on the investigators' criteria. RESULTS: Three hundred two studies were included, with varying diagnostic evaluations used to define PH. Commonly used diagnostic tests were right heart catheterization (56%) and transthoracic echocardiography (50%). The pooled prevalence for PH in general populations with ILD was 36% (95% CI, 30%-42%) using right heart catheterization and 34% (95% CI, 29%-38%) using transthoracic echocardiography. Lower diffusion capacity of the lungs for carbon monoxide, worse oxygenation status, reduced exercise capacity, increased pulmonary artery to aorta ratio and pulmonary artery diameter, and elevated serum brain natriuretic peptide consistently were associated with the presence of PH in at least 60% of reported studies. The presence of PH was associated with increased symptom burden and worse prognosis. Outcome measures in interventional trials of PH in ILD focused on changes in pulmonary vascular hemodynamics and 6-min walk distance. INTERPRETATION: PH is a common complication in ILD with significant health impacts. A standardized definition with prospective evaluation of risk-stratified assessments for PH using identified associated risk factors is warranted. Our findings provide an evidence base for validation as surrogate end points in future PH interventional trials in ILD. TRIAL REGISTRY: International Prospective Register of Systematic Reviews; No.: CRD42021255394; URL: https://www.crd.york.ac.uk/prospero/.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ang HL, Schulte M, Chan RK, et al. Pulmonary Hypertension in Interstitial Lung Disease: A Systematic Review and Meta-Analysis. Chest. 2024. PMID: 38821182. doi:10.1016/j.chest.2024.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。